Shimyn Slomovic

Executive Director Head of Gene Therapy R & d @Fractyl Health

Arlington, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Executive Director Head of Gene Therapy R & d @Fractyl Health

View department →

EDUCATION

2000 — 2003

Technion - Israel Institute of Technology

Bachelor of Arts (B.A.), Molecular Biology

2003 — 2009

Technion - Israel Institute of Technology

Doctor of Philosophy - PhD, Molecular Biology

SKILLS

Protein EngineeringTransfectionSynthetic BiologyPolymerase Chain Reaction (Pcr)BiotechnologyProtein PurificationGene ExpressionSds-PageResearchProtein ChemistryInnovationTissue CultureRnaMolecular CloningScienceBiochemistryFacsCellMolecular BiologyFluorescence MicroscopyCell CultureWestern BlottingDnaReal-Time Polymerase Chain Reaction (Qpcr)Cell-Free Protein ExpressionMammalian Cell CultureBiomedical EngineeringFlow CytometryPurificationProtein ExpressionMicroscopyGeneticsCell BiologyRnaiLife Sciences

ABOUT SHIMYN SLOMOVIC

Discovery and Development Leader - Gene therapy, nucleic acid and protein analysis, RNA biology, AAV capsid engineering, high throughput library screening, cell-free diagnostics, molecular and synthetic biologyBiotech cofounder and Head of Biology - Grew Dyno Therapeutics from sole employee to 30+ Team establishing an industry-leading AAV capsid engineering companyProgram Leader: Led Ascidian’s most advanced program from early Discovery to IND, including oversight of multiple in vivo studies, biochemical characterization, CRO/CDMO management, assay development/validation and regulatory documentation

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Shimyn Slomovic — Executive Director Head of Gene Therapy R & d at Fractyl Health in Arlington, MA, US | Unifers